课题基金 / 基金详情

项目摘要

项目成果

MACIEJ S LESNIAK的其他基金

相似基金

相关文献

中文摘要
翻译
行政核心:摘要 西北脑瘤孢子管理核心将为此提供结构和组织 研究计划,将在Lesniak博士(PI)、Heimberger博士(Co-I)和James的指导下运作 (co-I),孢子执行委员会提供的投入,以及内部和外部的指导 顾问委员会。核心领导是有经验的脑肿瘤研究人员,也是肿瘤专家。 生物学、实验治疗学、临床前和临床研究。因此,他们完全有资格 监督这个孢子,看看它的生产力以及对脑瘤治疗结果的影响 病人。根据委员会和顾问委员会的建议,核心董事将做出最终决定 对任何涉及孢子及时进程的问题的决定。此外,作为核心董事,他们将 对这个孢子负有全面的科学和财政责任。他们将支付资金并将收到 定期核算每个项目的财务状况。核心的工作人员支持将由Lurie提供 癌症中心(LCC)管理员Robin Leikin博士,赠款和合同管理员Daniel先生 Rademacher,项目/倡导管理员Laura Jaros女士和患者权益倡导者Mark Agnew。穿过 这些个人的努力和行政核心的活动、机制将到位并 适用于实现高质量、以团队为导向和富有成效的调查的程序。
英文摘要
ADMINISTRATIVE CORE: SUMMARY The Northwestern Brain Tumor SPORE Administrative Core will provide structure and organization to this program of research, and will function under the direction of Drs. Lesniak (PI) Heimberger (Co-I) and James (Co-I), with input from the SPORE Executive Committee, and with guidance from the Internal and External Advisory Boards. The core leaders are accomplished brain tumor researchers, and are experts in tumor biology, experimental therapeutics, and preclinical as well as clinical studies. As such they are well qualified to supervise this SPORE, and see to its productivity as well as impact on treatment outcomes for brain tumor patients. Based on committee and advisory board recommendations, the Core Directors will make final decisions on any issues that involve the timely progression of the SPORE. Further, as core directors they will have overall scientific and financial responsibility for this SPORE. They will disburse funds and will receive regular accounting of the financial status of each project. Staff support for the Core will be provided by Lurie Cancer Center (LCC) Administrator Dr. Robin Leikin, Grants and Contracts Administrator Mr. Daniel Rademacher, Program/Advocacy Administrator Ms. Laura Jaros, and patient advocate, Mark Agnew. Through the efforts of these individuals and activities of the Administrative Core, mechanisms will be in place and procedures applied for enabling high quality, team-oriented, and productive investigations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
phase 1 adaptive dose-escalation study of mycophenolate mofetil (MMF) in combination with temozolomide (TMZ) for patients with newly diagnosed glioblastoma
Arginine Metabolism Regulates Myeloid Immune Suppression in Glioblastoma
Arginine Metabolism Regulates Myeloid Immune Suppression in Glioblastoma
SPORE for Translational Approaches to Brain Cancer
海外基金